In the US, Asenapine (asenapine systemic) is a member of the drug class atypical antipsychotics and is used to treat Bipolar Disorder, Post Traumatic Stress Disorder, Schizoaffective Disorder and Schizophrenia.
US matches:
- Asenapine
- Asenapine Sublingual
- Asenapine Maleate
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N05AH05
CAS registry number (Chemical Abstracts Service)
0065576-45-6
Chemical Formula
C17-H16-Cl-N-O
Molecular Weight
285
Therapeutic Category
Central stimulant
Chemical Names
(3aR,12bR)-rel-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole
(3aRS,12bRS)-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole (WHO)
Foreign Names
- Asenapinum (Latin)
- Asenapin (German)
- Asénapine (French)
- Asenapina (Spanish)
Generic Names
- Asenapine (OS: BAN)
- UNII-JKZ19V908O (IS)
- Asenapine maleate (OS: USAN)
- Org 5222 (IS)
- UNII-CU9463U2E2 (IS)
Brand Name
- Saphris
Schering-Plough, United States
International Drug Name Search
Glossary
BAN | British Approved Name |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment